Babies with Down syndrome could help delay the onset of Alzheimer's disease

July 3, 2014 by Annette Karmiloff-Smith
The future’s bright. Credit: spabis, CC BY-NC-ND

Alzheimer's disease is typically a disease of later life, and age is the biggest known risk factor for the condition. But babies with Down syndrome, who always develop brains like those with Alzheimer's later in life, don't always go on to develop dementia. A study that I am involved in, called LonDowNs, is now trying to find out why this may be, with the hope of finding ways to slow down the development of dementia.

The global economic cost of Alzheimer's is estimated to be US$1 trillion per year by 2050. Delaying the onset of the by only six years could reduce those affected and save more than $400 billion.

Alzheimer's disease causes memory loss, mood changes and problems with communicating and reasoning. Apart from age, other factors can increase the risk of an individual developing the condition. Some of these are lifestyle-related, such as smoking, diabetes or . Others are based in our biology.

My research group is studying babies with Down syndrome – a genetic disease that causes delayed physical growth – to find out more about the changes that occur in the brain during the development of Alzheimer's disease. Babies' brains can, it turns out, tell us quite a lot about .

Those with Down syndrome have an increased risk of developing Alzheimer's disease. Among those aged between 50 and 59 years, one in three suffer from dementia (the most common form of which is the Alzheimer's disease), if they also have Down syndrome. That proportion rises to one in two for those over 60 year of age.

The increased risk may have something to do with why Down syndrome occurs. Every one has two copies of 23 chromosomes, which make up all the genetic information in any human cell. Those with Down syndrome have three copies of chromosome 21, and the genetic code in this chromosome produces a protein, called amyloid-beta precursor protein (APP), which is implicated in Alzheimer's disease.

By the age of 30 the brains of all individuals with Down syndrome show a high number of "plaques", formed from a group of mangled APP molecules. Unlike in the general population, this process has been shown to start in infancy in those with Down syndrome.

What is interesting, however, is that, while all individuals with Down syndrome will ultimately develop the typical Alzheimer's brain pathology, not all of them get the disease in adulthood. Something is protecting some of them from developing dementia.

To find out what that protecting factor is, we need to study people with Down syndrome across all ages and understand the environmental, genetic and biological factors that affect them. We have now started working on doing that by first creating Down syndrome and Alzheimer's disease in mice. The results from this will help us shape how we study infants and adults.

We have recruited children between six months and five years of age. We will perform behavioural assessments through observation of the child with their parent or caregiver. For instance, some of these will involve eye tracking and assessments of memory and attention while the infant watches videos on a screen.

The hope is that, by identifying risk factors for during very early development, we may be able to help target preventative treatments for individuals with Down and subsequently the . It may lead to treatments that could slow down the cognitive decline seen in Alzheimer's disease, or even reverse it.

Explore further: New research suggests connection between white matter and cognitive health

Related Stories

New research suggests connection between white matter and cognitive health

April 7, 2014
A multidisciplinary group of scientists from the Sanders-Brown Center on Aging at the University of Kentucky have identified an interesting connection between the health of the brain tissue that supports cognitive functioning ...

UCI study reveals why Down syndrome boosts susceptibility to other conditions

January 11, 2013
A study led by UC Irvine researchers has revealed some of the underlying neural factors that explain why people with Down syndrome are more susceptible to Alzheimer's disease, diabetes and autistic spectrum disorders.

New lab model of Alzheimer's disease will help research

February 16, 2012
(Medical Xpress) -- A new way of studying Alzheimer’s disease in the laboratory has been developed by scientists at the Wellcome Trust and Cancer Research UK Gurdon Institute in Cambridge and will help researchers understand ...

Depression in the elderly linked to Alzheimer's risk

June 9, 2014
Many people develop depression in the latest stages of life, but until now doctors had no idea that it could point to a build up of a naturally occurring protein in the brain called beta-amyloid, a hallmark of Alzheimer's ...

Trial to test new drug that may slow Alzheimer's memory loss

June 25, 2014
(Medical Xpress)—A new research study at Northwestern Medicine and Rush University Medical Center is testing whether a new investigational treatment can slow the memory loss caused by Alzheimer's disease.

Are cardiac risk factors linked to less blood flow to the brain?

July 18, 2012
Metabolic syndrome, a term used to describe a combination of risk factors that often lead to heart disease and type 2 diabetes, seems to be linked to lower blood flow to the brain, according to research by the University ...

Recommended for you

Is the Alzheimer's gene the ring leader or the sidekick?

September 15, 2017
The notorious genetic marker of Alzheimer's disease and other forms of dementia, ApoE4, may not be a lone wolf.

Potential noninvasive test for Alzheimer's disease

September 6, 2017
In the largest and most conclusive study of its kind, researchers have analysed blood samples to create a novel and non-invasive way of helping to diagnose Alzheimer's disease and distinguishing between different types of ...

Researchers unlock the molecular origins of Alzheimer's disease

September 6, 2017
A "twist of fate" that is minuscule even on the molecular level may cause the development of Alzheimer's disease, VCU researchers have found.

Is dementia declining among older Americans?

September 5, 2017
(HealthDay)—Here's some good news for America's seniors: The rates of Alzheimer's and other forms of dementia have dropped significantly over the last decade or so, a new study shows.

Which genetic marker is the ring leader in the onset of Alzheimer's disease?

September 4, 2017
The notorious genetic marker of Alzheimer's disease and other forms of dementia, ApoE4, may not be a lone wolf.

A decline in navigational skills could predict neurodegenerative disease

August 30, 2017
Changes in how humans map their surroundings and construct and follow directions as they age have been understudied compared to effects on memory and learning. However, age-related declines in navigational ability are independent ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

interested-party10
not rated yet Jul 03, 2014
This article discusses different potential biological targets. One of the targets is brain inflammation. http://www.jneuro...nt/5/1/2

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.